Dr. Jensen has broad extensive experience as a CLIA director for laboratories performing chemistry, toxicology, and molecular genetic pathology within various disease systems including neurodiagnostics, gastrointestinal disease, skin cancer, and other areas. Notable CLIA directorships include:

• Laboratory Director of Prometheus Laboratories. Since 2023 Dr. Jensen has been directing Prometheus Laboratories, and has worked with Thierry Dervieux in the analytical and clinical validation of IBD Precis test.

• Laboratory Director of Skyline Diagnostics. Dr. Jensen has overseen the newest development of the Merlin CP-GEP test which has now reached NCCN guidelines designation for all pT1b and pT2a melanoma skin cancers.

• Founding CLIA director of Amprion diagnostics navigating Amprion's world-class synucleinopathy LDT through clinical commercialization and navigating pharmaceutical trial inclusion. CLIA/NYS director for Precision Diagnostics. (Past)

• Assistant director of Precision Diagnostics. (Past)

• Assistant director of Phelps Memorial Hospital, New York (Past)